Micelle-enhanced and terbium-sensitized spectrofluorimetric determination of gatifloxacin and its interaction mechanism

Shandong University, Jinan, PR China.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (Impact Factor: 2.13). 12/2008; 72(4):766-71. DOI: 10.1016/j.saa.2008.10.063
Source: PubMed

ABSTRACT A terbium-sensitized spectrofluorimetric method using an anionic surfactant, sodium dodecyl benzene sulfonate (SDBS), was developed for the determination of gatifloxacin (GFLX). A coordination complex system of GFLX-Tb(3+)-SDBS was studied. It was found that SDBS significantly enhanced the fluorescence intensity of the complex (about 11-fold). Optimal experimental conditions were determined as follows: excitation and emission wavelengths of 331 and 547nm, pH 7.0, 2.0x10(-4)moll(-1) terbium (III), and 2.0x10(-4)moll(-1) SDBS. The enhanced fluorescence intensity of the system (DeltaI(f)) showed a good linear relationship with the concentration of GFLX over the range of 5.0x10(-10) to 5.0x10(-8)moll(-1) with a correlation coefficient of 0.9996. The detection limit (3sigma) was determined as 6.0x10(-11)moll(-1). This method has been successfully applied to the determination of GFLX in pharmaceuticals and human urine/serum samples. Compared with most of other methods reported, the rapid and simple procedure proposed in the text offers higher sensitivity, wider linear range, and better stability. The interaction mechanism of the system is also studied by the research of ultraviolet absorption spectra, surface tension, solution polarity and fluorescence polarization.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A novel method for the determination of trace gatifloxacin was established by resonance fluorescence techniques. It was based on the fact that oxidation of rhodamin 6G by hydrogen peroxide and Cu2+ was inhibited by gatifloxacin in Tris-HCl buffer medium and in presence of cetyl trimethyl ammonium bromide. The enhanced intensity (ΔF) of resonance fluorescence at 540 nm was proportional to the concentration of gatifloxacin in the range of 9.8 × 10−3 − 1.75 µg mL−1. The limit of detection was 2.9 ng mL−1 and the average recovery was 101.8% (n = 6) for gatifloxacin. The present method was applied to the determination of trace gatifloxacin in milk and biological fluids, and the obtained results were in good agreement with those obtained by HPLC.
    Analytical Letters 02/2013; 46(3). DOI:10.1080/00032719.2012.723228 · 0.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Micelles are self-assembled aggregates that arrange themselves into spheres in aqueous media. When the surfactant concentration reaches the critical micelle concentration, extensive aggregation of the surfactant monomers occurs to form micelles. A micelle has both a hydrophilic and a hydrophobic part. This allows them to form a spherical shape and for their glycolipid and phospholipid components to form lipid bilayers. The importance of micelles is increasing because of their wide analytical applications. Recently, colloidal carrier systems have received much attention in the field of analytical chemistry, especially in luminescence enhancement applications. Copyright © 2014 John Wiley & Sons, Ltd.
    Luminescence 05/2014; 30(1). DOI:10.1002/bio.2694 · 1.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This work reports the development and optimization of a flow injection analysis system with fluorescence detection (FIA–FLUO) for gatifloxacin (GFX) determination in organized medium. The analytical system was based on the enhanced fluorescence of gatifloxacin in micellar medium containing sodium dodecyl sulfate (SDS) at pH 6.0. The influence of physical (carrier flow rate, sample volume and volume of reaction coil) and chemical (pH, concentration of buffer and concentration of SDS) parameters that could affect the performance of the FIA system was evaluated in order to reach optimum conditions in terms of sensitivity and analytical throughput. Under optimized conditions, the FIA–FLUO system allowed the injection of 40 samples per hour with a limit of quantification of 72 µg/L and a RSD of 3.5% at 0.20 mg/L. Real samples of commercial pharmaceutical formulations containing GFX were analyzed, and no statistical difference was observed between the results obtained using the developed system and those obtained using the reference method based on high-performance liquid chromatography with UV detection. Copyright © 2014 John Wiley & Sons, Ltd.
    Luminescence 07/2014; DOI:10.1002/bio.2736 · 1.68 Impact Factor


Available from